NaPi2b-targeted polymer antibody-drug conjugates and methods of use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11407825
SERIAL NO

16542642

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclose herein are dosing regimens for targeted NaPi2b antibody-drug conjugates for treating cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • MERSANA THERAPEUTICS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bergstrom, Donald A Winchester, US 8 10
Hailman, Eric P Lexington, US 2 0
Jarlenski, Donna M New Haven, US 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Feb 9, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 9, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 9, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00